Gjessing PF, Fuskevåg O, Hagve M, Revhaug A, Irtun Ø. Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs.
THE PHENOMENON OF INSULIN RESISTANCE is most commonly known as a chronic metabolic hallmark of type 2 diabetes mellitus. Acute insulin resistance, on the other hand, arises after any major trauma and has been shown to increase complication rates and even mortality among critically ill surgical intensive care patients (27) . Despite increasing interest and research on acute insulin resistance, the underlying mechanisms are still elusive, and further research is needed.
Hyperinsulinemic euglycemic clamping (HEC) was first introduced in 1979 by DeFronzo et al (7) and is still regarded as the gold standard in measurement of insulin sensitivity in vivo. The technique is based on infusion of insulin at a constant rate, whereas simultaneous infusion of glucose is titrated to euglycemia. Aside from non-insulin-dependent glucose uptake and residual endogenous release of glucose, the steady-state (SS) glucose infusion rate (GIR) equals the amount of glucose utilized in peripheral insulin-sensitive tissues, and thus, HEC gives a picture of whole body insulin sensitivity.
To separate changes in hepatic from peripheral insulin sensitivity, i.e., changes in rates of endogenous glucose release (EGR) from rates of whole body glucose disposal (WGD), HEC can be combined with tracer dilution methodology (6) . Prior to HEC, basal EGR and WGD are calculated during infusion of glucose tracer. The tracer infusion is then continued during the subsequent HEC, and glucose kinetics are calculated based on non-SS equations and the SS GIR necessary to maintain euglycemia. Further development of this method has shown that maintenance of constant tracer enrichment during clamping minimizes dependency on non-SS equations and generates more accurate data. A frequently used procedure is labeling of the glucose infusate at an atom percent enrichment (APE) approximately equal to that measured during basal SS condition, the so-called hot-GINF HEC (12, 18) . If a stable glucose tracer is used, knowledge of the approximate level of basal SS tracer enrichment is a prerequisite for correct labeling because immediate analysis during the procedure is not feasible.
The liver and peripheral tissues generally exhibit different degrees of insulin sensitivity (17) , and insulin resistance can be caused by unresponsiveness or insensitivity to the hormone or a combination of both (19) . Therefore, hot-GINF HEC performed at stepwise increasing insulin infusion rates, so-called step clamping, gives more detailed information about sites, degrees, and specific features of insulin resistance than a clamp performed at a single insulin infusion rate. Furthermore, when combined with other tracers and experimental procedures, including invasive techniques such as regional or organ-specific flowmetry and arteriovenous balance measurements, HEC also is a versatile tool for investigation of various non-glucose-related domains of the metabolic effects of insulin (6, 10) .
Accordingly, the aim of this study was to establish step hot-GINF HEC as a tool for assessment of hepatic and peripheral insulin sensitivity in studies on acute insulin resistance in anesthetized pigs. Second, to arrange for combination of step hot-GINF HEC with invasive research methods, we wanted to investigate whether surgical instrumentation would alter basal glucose kinetics and thereby change the premises for correct labeling of the glucose infusates.
MATERIALS AND METHODS

Animals
The protocols were approved by the committee of the Norwegian Experimental Animal Board, and all experiments were conducted in compliance with institutional animal care guidelines and the National Institutes of Health (NIH) Guide for the Care 
Anesthesia and Monitoring
After sedation by intramuscular injection of 15 mg/kg ketamine (Narcetan; Véloquinol, Ittigen, Switzerland), 1 mg/kg midazolam (Midazolam B. Braun; B. Braun, Melsungen, Germany), and 1 mg of atropine (Atropin; Nycomed Pharma, Asker, Norway), the pigs were cleaned and weighed. Following mask inhalation of 4% isoflurane (Isofluran Baxter; Baxter, Irvine, CA) in 100% O 2, the pigs were orotracheally intubated and gas anesthesia was continued throughout the experiments at a minimal alveolar concentration of 0.8 -1.5% mixed with 40 -60% oxygen. Deep anesthesia was induced through an iv bolus of 0.01 mg/kg fentanyl (50 g/ml Fentanyl-Hameln; Hameln Pharmaceuticals, Hameln, Germany) and maintained with iv infusion of 0.02 mg·kg Ϫ1 ·h Ϫ1 fentanyl and 0.3 mg·kg Ϫ1 ·h Ϫ1 midazolam. Respiration and minimal alveolar concentration were monitored through a Datex Capnomac ultima instrument (Datex, Tewksbury, MA) and adjusted according to blood gas analysis (ABL 800 FLEX; Radiometer, Copenhagen, Denmark) and snout reflex tests. Arterial pressure was measured through a 20-gauge arterial catheter (BD Arterial Cannula with FloSwitch; Ohmeda, Swindon, UK) placed in the superficial saphenous artery and was continuously monitored together with heart rate and body temperature. Heating blankets were used to maintain body core temperature at 38.5°C.
Infusions
The pigs were equipped with an 18-gauge iv catheter (Optiva 2 18 G; Medex Medical, Haslingden, UK) in an ear vein for infusion of 0.9% sodium chloride (9 mg/ml Natriumklorid; B. Braun), fentanyl, midazolam, insulin aspart (NovoRapid; Novo Nordisk, Copenhagen, Denmark), 20% glucose (200 mg/ml glucose; Fresenius Kabi, Uppsala, Sweden), and D- [6,6- 2 H2]glucose (Cambridge Isotope Laboratories). All animals received an initial iv volume load of 30 ml·kg Ϫ1 ·h Ϫ1 0.9% sodium chloride during the first 30 min of anesthesia, and the infusion was then continued at 10 ml·kg Ϫ1 ·h Ϫ1 . Potassium chloride (1 mmol/ml Kaliumklorid; B. Braun) was added to the continuous 0.9% sodium chloride infusion according to potassium levels measured hourly. Infusions were performed on calibrated infusion pumps (insulin and D- [6,6- 2 H2]glucose on Terufusion syringe pumps; Terumo Europe, Leuven, Belgium; and hot-GINF solution on Abbott Oximetrix Infusion Pump Model 3; Oximetrix).
Study Design
The study was divided into three separate substudies (Fig. 1) . In substudies A and B, eight pigs were examined in two stages separated by a 4-day interval. In substudy C, eight pigs were examined once. Substudy A was designed to yield prerequisite information on basal SS tracer enrichment in solely anesthetized pigs (control) for correct labeling of the step hot-GINF HEC glucose infusates. Second, we investigated whether surgical instrumentation (instrumentation), necessary for combination of step hot-GINF HEC with invasive research methods, would require a change in labeling of the glucose infusates due to alterations in basal glucose kinetics by elevated counterregulatory hormones. Substudy B was designed to delineate porcine insulin dose-response characteristics and to determine optimal insulin infusion rates for assessment of changes in hepatic and peripheral insulin sensitivity. Substudy C was designed to test the suitability of the step hot-GINF HEC technique for assessment of acute insulin resistance after major surgical trauma.
Study design substudy A. The glucose tracer was given as a 150-min long primed (6 mg/kg), continuous (0.12 mg·kg Ϫ1 ·min Ϫ1 ) infusion. The priming dose and infusion rate were calculated from the exponential decline of tracer enrichment after bolus injection of D- [6,6- 2 H2]glucose (pilot study; data not shown). Glucose kinetics were calculated based on tracer enrichment measured during the last 30 min of infusion. Circulating concentrations of insulin, cortisol, glucagon, epinephrine, norepinephrine, and C-peptide were measured 10 min before and 30 min prior to the end of tracer infusion. The pigs were reanesthetized after a period of 4 days, and the procedure was repeated after surgical instrumentation, consisting of a median laparotomy and groin incision followed by dissection of the portal vein, common hepatic artery, right renal artery and vein, superior mesenteric artery and vein, and right femoral artery and vein. Instrumentation as described and two-layer closure of the incisions added up to a total duration of ϳ1 h.
Study design substudy B. Primed, continuous tracer infusion (basal period) was commenced 150 min prior to and continued throughout three consecutive clamp periods. Three 120-min long clamps were performed at stepwise increasing insulin infusion rates while glucose (200 mg/ml) labeled with tracer at an APE according to the measured level of basal SS enrichment from substudy A was titrated to euglycemia at ϳ4.5 mmol/l. Tracer enrichment in arterial blood was measured every 10th min during the last 30 min of the basal and successive clamp periods. Serum insulin was measured 30 min prior to the end of the basal period and every 30th min during the last hour of the successive clamp periods. Circulating concentrations of cortisol, glucagon, epinephrine and norepinephrine, Cpeptide, and free fatty acids (FFA) were measured 30 min prior the end of the basal and clamp periods. Anesthesia was discontinued, the pigs were extubated, and after a period of 4 days the procedure was repeated with three different insulin infusion rates. On the basis of unpublished preliminary data, insulin infusion rates at 0.2, 0.8, and 1.6 mU·kg Ϫ1 ·min Ϫ1 and 0.4, 1.2, and 2.0 mU·kg Ϫ1 ·min
Ϫ1
were chosen to cover a wide array of serum insulin levels in the pig. Study design substudy C. A three-step clamp with insulin infusion rates at 0.4, 1.2, and 2.0 mU·kg Ϫ1 ·min Ϫ1 was performed after major surgical trauma consisting of a right-sided thoracotomy, midline laparotomy, total colectomy, and closure of the incisions. Tracer enrichment in arterial blood was measured every 10th min during the last 30 min of the basal and successive clamp periods. C-peptide was measured 30 min prior to the end of the basal and clamp periods. Serum insulin was measured 30 min prior to the end of the basal period and every 30th min during the last hour of the successive clamp periods.
Sampling and Chemical Analysis
During the clamps, arterial serum glucose concentrations were immediately determined every 5th min using the glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH) after rapid centrifugation of the blood samples to 14,000 rpm in a Hettich Micro 120 centrifuge (Hettich Zentrifugen, Tuttlingen, Germany). Plasma samples were immediately centrifuged at 4°C/2,010 g for 10 min, whereas serum samples were allowed to clot before serum extraction. All samples were stored at Ϫ70°C for later analysis. Serum insulin, serum C-peptide, and plasma glucagon were measured by RIA methods (Linco Research, St. Charles, MO). Serum cortisol concentrations were determined by electrochemiluminescence immunoassay on a Roche Modular E 170 analyzer (Roche Diagnostics, Basel, Switzerland). Plasma FFA were measured using a Wako HR series NEFA-HR(2) colorimetric assay kit (Wako Diagnostics, Richmond, VA) and a Wallac Victor 2 1420 Multilabel Counter (EG & G Wallac, Turku, Finland). For catecholamine measurements, blood with heparin (4 IU/ml), reduced glutathione (4.5 mmol/l), and EGTA (5 mmol/l) were kept on ice for 30 min before centrifugation at 1,000 g for 20 min at 4°C. Preparation and analysis of plasma were performed with the Plasma Catecholamine Kit (order no. 5000; Chromsystems, Munich, Germany) with a Dionex P680 and ASI-100 HPLC equipment (Dionex, Germering, Germany) and electrochemical detector (ESA Coulochem III; ESA Laboratories, Chelmsford, MA).
Determination of Tracer Enrichment
Chemicals. HPLC grade acetonitrile was supplied by Merck (Darmstadt, Germany). Milli-Q grade water was produced by a Millipore system (Millipore, Bedford, MA Sample preparation and liquid chromatography-tandem mass spectrometry. Protein precipitation was performed with the addition of 300 l of ice-cold acetonitrile and 20 l internal standard (1 mM) to 50 l of plasma samples, calibrators, and controls, followed by vortexing in 10 s and centrifugation for 5 min at 10,000 g. One hundred microliters of the acetonitrile extract was placed into autosampler vials before analysis by liquid chromatography-tandem mass spectrometry using the Waters Acquity UPLC system with an autosampler and a binary solvent delivery system (Waters, Milford, MA) interfaced to a Waters Micromass Quattro Premier XE benchtop tandem quadrupole mass spectrometer (Waters, Manchester, UK). The system was controlled by MassLynx version 4.1. The chromatography was performed on a Luna NH2 column: 150 ϫ 2.0 mm id, 5 m, 100 Å (Phenomenex, Torrance, CA). Mobile phase consisted of 90% acetonitrile in water with a flow rate of 0.7 ml/min (isocratic). The mass spectrometer was operated in negative electrospray ion mode, and spray voltage was 3 kV. Sample injection volume was 4 l and the injection interval was 5 min. The flow was diverted to waste before and after analytes of interest. Autosampler temperature was 5°C, desolvation gas temperature was 340°C, source temperature was 120°C, desolvation gas flow was 850 l/h, cone gas flow was 40 l/h, collision gas pressure was 4 ϫ 10 Ϫ3 mBar (argon), and ion energies were 1 V for both quadrupoles. For quantitative analysis, the following multiple reaction monitoring transitions were used: mass-tocharge ratio (m/z) 179¡89 and m/z 179¡119 for glucose; m/z 181¡89, m/z 181¡91, and m/z 181¡121 for D-[6,6-2 H2]glucose; ]glucose atom %enrichment; insulin, blood sampling for analysis of insulin; CRH/ C-P, blood sampling for analysis of counterregulatory hormones and C-peptide; FFA, blood sampling for analysis of free fatty acids. Substudy A: 8 pigs were examined in 2 stages separated by a 4-day interval. Basal steady-state tracer enrichment, stress hormone levels, and glucose kinetics were assessed first during tracer infusion in anesthetized condition only (control) and second after surgical instrumentation (instrumentation). Substudy B: 8 pigs were examined in 2 stages separated by a 4-day interval. Two step hot-GINF HEC (hyperinsulinemic euglycemic clamping) experiments were performed at a total of 6 different insulin infusion rates to delineate porcine insulin dose-response characteristics. Substudy C: a 3-step clamp with insulin infusion rates selected on the basis of the results from substudy B was performed after major surgery in 8 pigs to test the suitability of the technique for assessment of acute insulin resistance.
and multiple reaction monitoring transition m/z 185¡92 and m/z 185¡123 were used for the internal standard D-[
13 C6]glucose. The dwell time was set to 100 ms for each transition.
Calculations
Total glucose appearance rate (Ra) and WGD were calculated using modified versions of Steele's equations (11, 23) :
where F is the tracer infusion rate, E is the tracer enrichment, p is the pool fraction taken as 0.65 (11), V is the distribution volume of glucose taken as 230 ml/kg (22), C is the glucose concentration, and Q is the glucose pool size. F consisted of the continuous tracer infusion alone in substudy A and during basal in substudies B and C, as opposed to during clamp periods in substudies B and C, where F was the sum of the continuous tracer infusion and tracer infused with the hot-GINF infusate during the last 40 min of each clamp. A linear curve was fit to the glucose concentration and tracer enrichment raw data by linear regression to minimize analytical variation and improve accuracy of the calculations. EGR was calculated by subtracting GIR from the calculated R a.
Statistical Analysis
Data are presented as means Ϯ SE and were analyzed by Student's dependent and independent t-tests and one-way repeated-measures analysis of variance with Bonferroni correction for multiple comparisons where appropriate (SPSS 17 for Windows; SPSS, Chicago, IL). P Ͻ 0.05 was considered statistically significant.
RESULTS
Substudy A
Tracer enrichment and glucose kinetics. The mean intraindividual coefficient of variation (CV) of the four tracer enrichment and serum glucose measurements ranged from 4.7 Ϯ 0.4 to 7.3 Ϯ 1.4%, indicating SS conditions (Table 1) . Mean tracer enrichment and serum glucose were not statistically different before (control) and after surgical instrumentation (instrumentation) of the pigs, and glucose kinetics remained unchanged with EGR of 5.62 Ϯ 0. 16 Circulating hormone concentrations. All measured hormone concentrations, including counterregulatory hormones, remained unchanged, indicating a lack of stress responses to the surgical instrumentation (Table 2) .
Substudy B
Insulin dose-response characteristics. The timelines of GIR, tracer APE, and serum glucose concentrations during the step clamps are shown in Fig. 2 . As shown in Table 3 , mean glucose concentration was significantly higher during the basal period of the first step clamp compared with the basal period of the second step clamp, but both concentrations were well within the normal fasting range. The mean intraindividual CV of serum glucose and tracer enrichment during the last 30 min of each step clamp ranged from 3. (Table 3 ). All calculated values for EGR and WGD put together revealed a relative difference in insulin responsiveness of the liver and peripheral tissues with abruptly diminishing EGR at modest insulin infusion rates, whereas higher infusion rates were needed to elicit a strong increase in WGD (Fig. 3) . Based on the determined insulin dose-response characteristics and the linear relationship of infused vs. circulating insulin, the calculated half-maximal effective insulin doses for EGR and WGD were ϳ9 and 15 U/ml, respectively.
Circulating hormone and FFA concentrations. Significant fluctuations of circulating glucagon during the step clamp procedures were detected. Except for these variations, no significant differences in hormone concentrations were observed between or within each experiment. Mean plasma FFA decreased to approximately one-half of basal levels and remained stable during the step clamps, probably due to insulin inhibition of lipolysis (Table 4) .
Substudy C
Insulin and C-peptide. Compared with the second step clamp in substudy B, serum insulin was significantly higher during all clamps despite identical insulin infusion rates. As in substudy B, endogenous insulin release was completely abolished by the exogenous insulin infusion, as indicated by undetectable levels of C-peptide (Table 3) , and therefore, it can be concluded that the increase in circulating insulin was probably due to a reduction in metabolic insulin clearance.
Glucose kinetics and tracer enrichment. Although a greater intraindividual variation in tracer enrichment was seen during the postoperative step clamp than during clamps in substudy B, the mean intraindividual CV of serum glucose, tracer enrichment, and GIR together indicated adequately stable clamping conditions (Table 3 and Figs. 2-4) . Postoperative mean basal glucose concentration was significantly higher than during the second step clamp (P Ͻ 0.05) but not compared with the first step clamp in substudy B. GIR, tracer APE, and serum glucose concentration timelines for all step clamps are shown in Fig. 2 . Due to higher levels of circulating insulin during substudy C than during substudy B, not all glucose kinetics data were directly comparable (Fig. 3) . Therefore, differences in metabolic effects of low and high insulin were calculated by comparison of data from postoperative clamps 1 and 2 to the data from clamps 2 and 6 in substudy B, since the respective levels of circulating insulin during these clamps were similar. Too high insulin levels rendered the third postoperative clamp not directly comparable with any clamp in substudy B. Postoperatively, GIR was 56 and 31% (both P Ͻ 0.001) lower during low and high insulin, respectively. WGD was 45 and 28% lower (both P Ͻ 0.001) during low and high insulin, respectively, and even during postoperative clamp 3, WGD was 13% (P Ͻ 0.05) lower than during clamp 6 in substudy B despite twice as high insulin levels. Calculated as percent change from basal, significantly less increase in WGD was measured postoperatively during both low and high insulin (170 Ϯ 25 vs. 39 Ϯ 5%, P Ͻ 0.001, and 275 Ϯ 24 vs. 156 Ϯ 15%, P ϭ 0.001), and EGR was significantly less suppressed by insulin after surgery during low (66 Ϯ 2 vs. 85 Ϯ 5%, P Ͻ 0.01) but not during high insulin (84 Ϯ 6 vs. 91 Ϯ 5%, P ϭ 0.39).
DISCUSSION
This study reports for the first time implementation of step hot-GINF HEC for assessment of acute hepatic and peripheral insulin sensitivity in a porcine model and determination of insulin dose-response characteristics for endogenous glucose release and utilization in anesthetized pigs by this technique.
Step hot-GINF HEC can be used in both operated and surgically untouched animals, making it suitable for studies on acute insulin resistance. It is characterized by high reproducibility, flexible and controllable glucose and insulin concentrations, and easy combination with complementary investigative techniques such as different tracers, indirect calorimetry, and regional artero-venous balance (8, 10) . When performed during anesthesia, clamping can also be combined with other invasive procedures that are hardly feasible in conscious animals.
Various hyperinsulinemic clamps have previously been applied in porcine experiments to examine different metabolic effects of insulin. Insulin sensitivity and glucose metabolism in particular have been assessed with clamping alone or in combination with glucose tracers, and in a limited number of studies tracer enrichment was kept constant by either increased infusion rates during clamping or addition of tracer to the glucose infusate (1, 3, 21) . Most often, single clamps were performed, and insulin infusion rates differed widely among studies. Also, the age and race of the pigs, anesthetic regime or conscious restraint, and hormonal and metabolic substrate manipulation varied with experimental design. Owing to the relatively small amount and limited comparability of existing data, we sought to establish and test the step hot-GINF HEC technique before implementation in porcine studies on acute insulin resistance.
Because considerable differences regarding basal glucose kinetics exist between species, specific tracer glucose infusion rates are necessary to achieve adequate tracer enrichment levels. Anesthesia in general alters glycemic homeostasis, and inhalation anesthetics in particular are known to diminish glucose-stimulated insulin secretion (24) . If combined with invasive experimental techniques, these basal premises for utilization of step hot-GINF HEC might additionally be altered by elevated counterregulatory hormones due to surgical instrumentation. Therefore, in substudy A, basal glucose kinetics and levels of tracer enrichment and counterregulatory hormones were measured during tracer infusion in a uniform group of eight pigs submitted to a standardized anesthetic regime. After Fig. 2. Step clamp timelines. Timelines during step hot-GINF HEC procedures (n ϭ 8). GIR, glucose infusion rate; S-glucose, serum glucose. Data are means Ϯ SE. a 4-day interval, the procedure was repeated to survey possible alterations following extensive surgical instrumentation.
Different species also exhibit different insulin clearance rates and sensitivity (5, 20) , and generally, the liver is more sensitive to insulin than peripheral tissues. Also, insulin resistance can be caused by insensitivity or unresponsiveness to the hormone or even both. These distinctive features of insulin resistance serve as indicators of pre-and post-insulin receptor defects (19) . Therefore, to adequately separate specific sites and characteristics of insulin resistance, examination of the biological effects of insulin at different and carefully selected serum concentrations is mandatory. Thus, a second group of pigs was used to determine dose-response characteristics of endogenous glucose release and utilization to a wide range of insulin infusion rates. On the basis of the dose-response data, three insulin infusion rates were selected and combined in a final step clamp performed in a third group of pigs following major surgery to test the suitability of the method for assessment of acute insulin resistance.
In substudy A, a change in liver insulin sensitivity after instrumentation cannot be excluded because this was not assessed. However, the unaltered SS serum glucose and EGR indicated that basal liver glucose kinetics were unaffected, and thus, instrumentation as described does not necessitate a change in labeling of the glucose infusates. Peripheral glucose uptake in the postabsorptive state is mainly non-insulin dependent, and although early development of muscle insulin resistance due to the instrumentation cannot be ruled out in our study, the unaltered serum glucose, insulin, and C-peptide concentrations weigh against it. The fact that no statistically significant changes in circulating concentrations of insulin, cortisol, glucagon, epinephrine, and norepinephrine after instrumentation were detected can be explained by suppressive effects of anesthesia on release of counterregulatory hormones or the fact that the surgical trauma was too limited to induce such a release.
In substudy B, it could be argued that an actual SS was never achieved during clamp periods 1 and 4, as glucose infusion rate Table 3 . Substudies B and C: insulin, C-peptide, glucose kinetics, and tracer enrichment during step clamps Substudy B
Substudy C
Step hot-GINF HEC 1
Step hot-GINF HEC 2
Step hot-GINF HEC after surgery slowly continued to rise. However, clamping conditions were accepted as adequately stable considering the stable serum glucose and tracer enrichment levels and the reasonable results. Compared with other species, pigs exhibit a high rate of insulin clearance (20) , and despite a relatively high maximal insulin infusion rate at 2.0 mU·kg Ϫ1 ·min Ϫ1 , a mean serum insulin concentration of only 31.6 U/ml was achieved. However, this was sufficient to elicit peak metabolic efficiency in the liver and peripheral tissues and totally diminish endogenous insulin secretion, demonstrated by undetectable levels of C-peptide. The experiments were performed using the modified insulin aspart, which in pilot studies from our own laboratory exhibited equal metabolic effects but higher clearance rates than native human and porcine insulin (data not shown).
Circulating levels of cortisol, glucagon, and catecholamines remained stable within physiological ranges normally seen in conscious pigs used in biomedical research (16) . Infusion of insulin during the step clamp approximately halved plasma FFA from basal levels. A downward trend, but no statistically significant difference in circulating FFA, was detected between the three consecutive clamp procedures. Thus, influence by the classical counterregulatory hormones or the glucose-fatty acid cycle (14) on the measured insulin dose-response characteristics is unlikely. The finding that the liver is about two times more sensitive to insulin than peripheral tissues is not unique to pigs but in accord with human insulin dose-response characteristics (17) . Also in accord with previous data (1, 21) , the basal glucose turnover rate and maximal rate of glucose utilization were approximately two times higher than those found in similar studies in man (17) .
Reduced insulin responsiveness is indicated by a shift of the insulin dose-response curve to the right and should therefore be measured with hot-GINF HEC at serum insulin corresponding to the end of the steepest part of the dose-response curves. Insulin insensitivity, on the other hand, is best detected at higher insulin levels, where EGR is almost completely suppressed and WGD is reaching its limits. This does not necessarily require tracer methodology, provided normal suppression of EGR. Apparently, diminished insulin clearance resulted in higher postoperative serum insulin levels, precluding a direct step clamp comparison between substudies B and C. Clamp data compared on the basis of matching serum insulin levels revealed pronounced peripheral and moderate hepatic insulin unresponsiveness after surgery. Furthermore, WGD persistently failed to reach the maximal rate measured in solely anesthetized pigs, even at twice the level of serum insulin, indicating a component of peripheral insulin insensitivity. Postoperatively, no significant change in suppression of EGR was measured during high serum insulin (Fig. 4) . These results are in accord with human studies on acute insulin resistance after elective surgery (25) .
Published data on insulin clearance after trauma have been contradictory. It has been reported to be increased in patients with multiple injuries (2), unchanged after severe scald injury in rats (15) , and decreased during hypovolemic shock in primates (4), indicating the possibility for both species and trauma variations. The mechanism of diminished insulin degradation is not apparent from the present study. However, metabolic insulin clearance during physiological hyperinsulinemia is inseparably linked to insulin action, since binding to the insulin receptor constitutes the first step of degradation (9) and substantially decreased insulin clearance has been demonstrated in patients suffering from type 2 diabetes mellitus, obesity, and other conditions characterized by severe target cell insulin resistance (13, 26) .
In conclusion, step hot-GINF HEC is a feasible technique for assessment of insulin sensitivity in anesthetized pigs and seems well suited for porcine research models on acute insulin resistance, but attention must be paid to alterations in metabolic insulin clearance. Combination with invasive research techniques requiring extensive surgical instrumentation can be accomplished without circulating levels of counterregulatory hormones, basal glucose kinetics, or tracer enrichment levels being altered. The insulin dose-response characteristics established in the present study suggest appropriate insulin infusion Step Hot-GINF HEC 1
Step Hot-GINF HEC 2 IIR, mU ⅐ kg Ϫ1 ⅐ min rates for detection of hepatic and peripheral insulin unresponsiveness and insensitivity.
